Retrospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Oct 28, 2018; 24(40): 4596-4605
Published online Oct 28, 2018. doi: 10.3748/wjg.v24.i40.4596
Table 4 Univariate and multivariate analyses for predictors of failed Helicobacter pylori eradication
FactorEradication rate
P value1Multivariate2
n/N (%)OR (95%CI)P value
Age (yr)< 60781/827 (94.4)0.96--
≥ 60156/165 (94.5)
GenderMale469/501 (93.6)0.24--
Female468/491 (95.3)
Education2< 7 yr150/164 (91.5)0.29--
7-9 yr237/249 (95.2)
10-12 yr187/197 (94.9)
13-16 yr219/229 (95.6)
> 16 yr20/20 (100)
Number of previous H. pylori treatment(s)None800/842 (95.0)0.002Reference-
One119/127 (93.7)1.2 (0.5-2.7)0.73
Two or more18/23 (78.3)7.4 (2.2-24.9)0.001
DiagnosisFunctional dyspepsia453/478 (94.8)0.49--
Peptic ulcers245/259 (94.6)
Erosive esophagitis67/69 (97.1)
Other sources of upper GI bleeding4/5 (80.0)
Gastric neoplasm6/6 (100.0)
Asymptomatic gastritis68/75 (90.7)
13C-UBT positive during health checkup94/100 (94.0)
PPI typeEsomeprazole253/264 (95.8)0.42--
Rabeprazole209/224 (93.3)
Pantoprazole408/435 (93.8)
Other PPIs67/69 (97.1)
Bismuth400 mg per day204/213 (95.8)0.4--
600 mg per day371/391 (94.9)
800 mg per day362/388 (93.3)
Duration of regimen10 d19/21 (90.5)0.33--
14 d918/971 (94.5)
Adherence2Took 80% medicine or more782/819 (95.5)< 0.001Reference-
Took less than 80% medicine31/40 (77.5)6.7 (2.8-15.8)< 0.001
Smoking2Non-smoker631/660 (95.6)0.004Reference-
Abstinence during therapy77/80 (96.3)0.7 (0.2-2.7)0.65
Smoking during therapy105/119 (88.2)1.9 (0.9-4.3)0.10
Alcohol2Non-alcohol user600/628 (95.5)< 0.001Reference-
Abstinence during therapy186/197 (94.4)1.0 (0.4-2.3)1.00
Alcohol use during therapy27/34 (79.4)4.4 (1.5-12.3)0.008